Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael M Lederman

Showing results (231-240 of 303) with videos related to

Pageof 31
Sort By:
JCI Insight|May 6, 2020
Inflammescent CX3CR1+CD57+CD8+ T cells are generated and expanded by IL-15Stephen R Morris, Bonnie Chen, Joseph C Mudd, et al.
The Journal of Infectious Diseases|April 24, 2014
Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infectionPeter W Hunt, Elizabeth Sinclair, Benigno Rodriguez, et al.
Science Translational Medicine|July 12, 2013
Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolismIvan Vujkovic-Cvijin, Richard M Dunham, Shoko Iwai, et al.
Plos One|May 16, 2019
HIV infection is associated with elevated biomarkers of immune activation in Ugandan adults with pneumoniaRichard J Wang, Julia Moore, Daniela Moisi, et al.
The Journal of Infectious Diseases|October 5, 2010
Determinants of protection among HIV‐exposed seronegative persons: an overviewMichael M Lederman, Galit Alter, Demetre C Daskalakis, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 26, 2018
Anisocytosis and leukocytosis are independently related to survival after transcatheter aortic valve replacementGuilherme F Attizzani, Sadeer G Al-Kindi, Jarrod E Dalton, et al.
JAMA|September 28, 2006
Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infectionBenigno Rodríguez, Ajay K Sethi, Vinay K Cheruvu, et al.
Archives of Internal Medicine|March 29, 2007
The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328Ronald Mitsuyasu, Rebecca Gelman, Deborah Weng Cherng, et al.
Plos Pathogens|October 19, 2019
Fingolimod retains cytolytic T cells and limits T follicular helper cell infection in lymphoid sites of SIV persistenceMaria Pino, Sara Paganini, Claire Deleage, et al.
Frontiers in Immunology|August 15, 2022
Methotrexate Inhibits T Cell Proliferation but Not Inflammatory Cytokine Expression to Modulate Immunity in People Living With HIVMichael L Freeman, Brian M Clagett, Daniela Moisi, et al.
Pageof 31

Showing results (231-240 of 303) with videos related to

Sort By:
Pageof 31
JCI Insight|May 6, 2020
Inflammescent CX3CR1+CD57+CD8+ T cells are generated and expanded by IL-15Stephen R Morris, Bonnie Chen, Joseph C Mudd, et al.
The Journal of Infectious Diseases|April 24, 2014
Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infectionPeter W Hunt, Elizabeth Sinclair, Benigno Rodriguez, et al.
Science Translational Medicine|July 12, 2013
Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolismIvan Vujkovic-Cvijin, Richard M Dunham, Shoko Iwai, et al.
Plos One|May 16, 2019
HIV infection is associated with elevated biomarkers of immune activation in Ugandan adults with pneumoniaRichard J Wang, Julia Moore, Daniela Moisi, et al.
The Journal of Infectious Diseases|October 5, 2010
Determinants of protection among HIV‐exposed seronegative persons: an overviewMichael M Lederman, Galit Alter, Demetre C Daskalakis, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 26, 2018
Anisocytosis and leukocytosis are independently related to survival after transcatheter aortic valve replacementGuilherme F Attizzani, Sadeer G Al-Kindi, Jarrod E Dalton, et al.
JAMA|September 28, 2006
Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infectionBenigno Rodríguez, Ajay K Sethi, Vinay K Cheruvu, et al.
Archives of Internal Medicine|March 29, 2007
The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328Ronald Mitsuyasu, Rebecca Gelman, Deborah Weng Cherng, et al.
Plos Pathogens|October 19, 2019
Fingolimod retains cytolytic T cells and limits T follicular helper cell infection in lymphoid sites of SIV persistenceMaria Pino, Sara Paganini, Claire Deleage, et al.
Frontiers in Immunology|August 15, 2022
Methotrexate Inhibits T Cell Proliferation but Not Inflammatory Cytokine Expression to Modulate Immunity in People Living With HIVMichael L Freeman, Brian M Clagett, Daniela Moisi, et al.
Pageof 31